Talking KRAS-Targeted Therapy in NSCLC With Dr. Drilon

In our exclusive interview, Alexander Drilon, MD, discusses some of the historical challenges of targeting KRAS and provided perspective on available and anticipated data with AMG 510 in non–small cell lung cancer.